Molecular Diagnostics
Testing for Biomarkers in Urine and Blood Can Predict Patient’s Risk of Developing Chronic Kidney Disease
In a new study that examined the long-term consequences of acute kidney injury in hospitalized patients, researchers have found that elevated levels of specific biomarkers in urine and blood can predict a patient's likelihood of developing chronic kidney disease. More...04 Apr 2023
Non-Invasive Diagnostic Test Improves Detection of Oral Cancer
Scientists have developed PANDORA, a proof-of-concept test that demonstrated over 92% accuracy in identifying patients with oral squamous cell carcinoma and over 80% accuracy in detecting pre-cancer or oral epithelial dysplasia. More...04 Apr 2023
Digital PCR Platform Harnesses Microfluidic Technology for Quantification of Genetic Targets
An easy-to-use dPCR platform harnesses cutting-edge microfluidic technology to integrate the dPCR workflow onto a single consumable chip, resulting in higher sensitivity and accuracy when detecting low-level abundance nucleic acids in the detection of bacterial and viral pathogens. More...03 Apr 2023
New Integrated PCR Solutions Offer Flexibility and Portability for Small Laboratories and On-Site Testing
Tianlong Science and Technology, an innovative high-tech company that specializes in molecular diagnostic products, has launched two new products, the GeneFlex Nucleic Acid Extractor and the Gentier mini+ Real-time PCR System, globally. More...03 Apr 2023
Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment
Scientists researching the origins of systemic lupus erythematosus and the reasons why some patients have more severe symptoms than others have discovered a type of autoantibody that could worsen the disease and identified how these autoantibodies are formed. More...31 Mar 2023
Blood Test for Multiple Pathways Related to Alzheimer’s Could Enable Earlier and Less-Invasive Diagnosis
A five-year, USD 41 million study, titled Centrally-linked Longitudinal Peripheral Biomarkers of AD, or CLEAR-AD, that involves over 40 experts and 13 institutions across the U.S. and abroad, will facilitate collaboration and promote progress in Alzheimer's disease research through several innovative approaches. More...31 Mar 2023
POC Test Detects Genetic Blood Disorders with High Accuracy
Sickle cell disease (SCD) and beta thalassemia are genetic blood disorders that affect over 7% of the global population. In the US, SCD is estimated to affect 100,000 people, with up to 8% of African-Americans being carriers, and can reduce life expectancy by up to 20 years. Now, an affordable sickle cell and beta thalassemia test that is currently used in 27 countries seeks to replicate its international success and expand into the U.S. More...31 Mar 2023
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Hemodynamic System Monitor
OptoMonitor
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
In Other News
Non-Invasive Fecal DNA Test Accurately Detects Colorectal Cancer and Precancerous Lesions
Simple Blood Test Could Help Doctors Diagnose Heart Disease in Physician's Office
Serum Protein Test Can Predict Outcomes for Liver Failure Patients
Fully Automated Blood-Based Assays Measure Biomarker for Neurodegenerative Diseases within 35 Minutes
POC Fingerprick Test Identifies Both HIV-1/2 and Syphilis Antibodies from One Sample within 60 Seconds
Transformative NGS Innovation Expands Access to Genomic Testing for Tuberculosis Patients
Quick, Affordable Finger-Prick Test Diagnoses Common STI in Five Minutes
Automated Sample-to-Result PCR Test Enables Rapid Genotyping for Antiplatelet Therapy
Handheld Molecular POCT System Enables Rapid Onsite Testing at Hospital ERs and Clinics
Next Gen Technology Enables Robust, Straightforward and Flexible Molecular Diagnostics in Any Environment
Portable PCR Molecular Analyzer Delivers Time-Critical Results in Near-Patient Setting
First-of-Its-Kind Test Helps Determine Future Risk of Esophageal Cancer
Handheld Immunoanalyzer Performs Laboratory Tests near Patient without Sacrificing Sensitivity and Precision
Point-of-Care MDx System Enables Simple, Fast and Accurate Diagnosis in Near Patient Setting
Near-Patient Molecular Test Outperforms Other Rapid Measures for Sepsis Diagnosis
Biomarker-Based Approach Could Identify Early Risk of Pancreatic Cancer
Simple, Inexpensive Genetic Test Can Identify MS Patients at Risk of Fatal Brain Infection
Unique Dye-Based Tests to Revolutionize Early-Detection Pancreatic Cancer Diagnostics
Novel Lymph Liquid Biopsy Could Transform Approach for Identifying Cancer Recurrence Risk
First-of-Its-Kind High-Throughput Diagnostic Test for Infectious Vaginitis Uses Only One Swab
Novel Biosensor to Detect DNA Damage in Real Time Could Revolutionize Cancer Treatment
High-Sensitivity Troponin I Could Predict Preeclampsia in High-Risk Women
‘Glow-In-The-Dark’ Proteins to Help Diagnose Viral Diseases More Quickly and Easily
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
